23.43
Schlusskurs vom Vortag:
$23.36
Offen:
$23.35
24-Stunden-Volumen:
1.09M
Relative Volume:
1.19
Marktkapitalisierung:
$2.95B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$27.39M
KGV:
139.63
EPS:
0.1678
Netto-Cashflow:
$136.77M
1W Leistung:
+8.32%
1M Leistung:
+1.83%
6M Leistung:
-5.94%
1J Leistung:
+3.22%
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
23.43 | 2.95B | 2.25B | 27.39M | 136.77M | 0.1678 |
|
VEEV
Veeva Systems Inc
|
159.54 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
63.23 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
47.82 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
88.34 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
65.34 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Renaissance Group LLC Invests $7.78 Million in Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health stock consolidates near weekly highs as technicals suggest mild downside risk - Traders Union
Privia's CEO Just Sold 121,000 Shares for $2.7 Million - Yahoo Finance
Privia Health Group (PRVA) Edges Higher Amid Sector Optimism: Key Levels to WatchIchimoku Cloud - newsline.com
Privia Health Group, Inc. - MLQ.ai
What Privia Health Group (PRVA)'s New Jersey Neurology Anchor Deal Means For Shareholders - simplywall.st
PRVA Q1 2026 Earnings: EPS Falls Short but Stock Rises on Market OptimismHealthcare Earnings Report - newsline.com
Understanding Momentum Shifts in (PRVA) - Stock Traders Daily
How The Privia Health Group (PRVA) Narrative Is Shifting With Mixed Targets And New Deals - Yahoo Finance
Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
PRVA News | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
A Look at Privia Health Group Inc (PRVA) After 3.4% Gain -- GF V - GuruFocus
Privia Health earnings on deck as analysts eye provider expansion - Investing.com
PRVA Technical Analysis | Trend, Signals & Chart Patterns | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? - The Globe and Mail
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? - The Motley Fool
PRVA Q1 2026 Earnings: EPS Misses Estimates Amid Operational HeadwindsFree Cash Flow Trends - The League of Women Voters of Texas
Free cash flow per share of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Physician network Privia Health enters New Jersey - ROI-NJ
Privia Health Group Enters New Jersey - Moomoo
Privia Health expands to New Jersey, partnering with Neurology Group of Bergen County. - Pluang
New Jersey neurology care to expand as Privia joins 25-clinician group - Stock Titan
TBRG vs. PRVA: Which Stock Is the Better Value Option? - Yahoo Finance
PRVA Maintained by Barclays -- Price Target Lowered to $24.00 - GuruFocus
Avoiding Lag: Real-Time Signals in (PRVA) Movement - Stock Traders Daily
PRVA Q1 2026 Earnings: Profit Miss Overshadowed by Slight Stock GainGuidance Accuracy Score - The Legal Advocate
Privia Health Group shareholders approve all proposals at annual meeting By Investing.com - Investing.com India
Privia Health Group, Inc. 8-K Filing May 2026: Executive Compensation Vote Results and Company Information - Minichart
Privia Health Group shareholders approve all proposals at annual meeting - Investing.com
Privia Health (PRVA) director receives 8,463 restricted stock units as equity award - Stock Titan
Privia Health (PRVA) director receives 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 RSUs in equity grant - Stock Titan
Privia Health (PRVA) director McCarthy granted 8,463 RSUs and updates holdings - Stock Titan
Privia Health Group (PRVA) director awarded 8,463 restricted stock units - Stock Titan
Privia Health Group (PRVA) director Jaewon Ryu granted 8,463 restricted stock units - Stock Titan
Director at Privia Health (PRVA) receives 8,463 RSU grant as board compensation - Stock Titan
Privia Health (PRVA) director Francis Soistman files initial Form 3 with no holdings - Stock Titan
Privia Health (NASDAQ: PRVA) holders approve directors, pay and auditor - Stock Titan
Privia Health Up Slightly; 2026 Growth Plan Still Ahead - Bez Kabli
A Look At Privia Health Group (PRVA) Valuation After Q1 Results And Maintained 2026 Revenue Guidance - simplywall.st
BMO Capital Initiates Coverage of Privia Health Group (PRVA) with Outperform Recommendation - MSN
Privia Health Group CEO & Director Parth Mehrotra Sells 47% Of Holding - simplywall.st
What to expect from Privia Health’s (PRVA) Q1 earnings - MSN
Discipline and Rules-Based Execution in PRVA Response - Stock Traders Daily
Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point - simplywall.st
Statutory Profit Doesn't Reflect How Good Privia Health Group's (NASDAQ:PRVA) Earnings Are - Yahoo Finance
Privia Health Group Insider Sold Shares Worth $2,731,898, According to a Recent SEC Filing - Moomoo
Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 105,439 Shares of Stock - MarketBeat
Privia Health CEO sells over $2.7m in company stock - Investing.com
Privia Health CEO sells over $2.7m in company stock By Investing.com - Investing.com Nigeria
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):